Seaweed‑associated heterotrophic bacteria: new paradigm of prospective anti‑infective and anticancer agents

Vinaya, K K and Chakraborty, Kajal (2021) Seaweed‑associated heterotrophic bacteria: new paradigm of prospective anti‑infective and anticancer agents. Archives of Microbiology, 203 (3). pp. 1241-1250.

[img] Text
Archives of Microbiology_2021_Kajal Chakraborty.pdf
Restricted to Registered users only

Download (1MB) | Request a copy | Please mail the copy request to cmfrilibrary@gmail.com
Official URL: https://link.springer.com/article/10.1007/s00203-0...
Related URLs:

    Abstract

    Ever since the development of the first antibiotic compound with anticancer potential, researchers focused on isolation and characterization of prospective microbial natural products with potential anti-infective and anticancer activities. The present work describes the production of bioactive metabolites by heterotrophic bacteria associated with intertidal seaweeds with potential anti-infective and anticancer activities. The bacteria were isolated in a culture-dependent method and were identified as Shewanella algae MTCC 12715 (KX272635) and Bacillus amyloliquefaciens MTCC 12716 (KX272634) based on combined phenotypic and genotypic methods. Further, the bacteria were screened for their ability to inhibit drug-resistant infectious pathogens and prevent cell proliferation of human liver carcinoma (HepG2) and breast cancer (MCF7) cell lines, without affecting the normal cells. Significant anti-infective activity was observed with bacterial cells and their organic extracts against broad-spectrum multidrug-resistant pathogens, such as vancomycin-resistant Enterococcus faecalis, methicillin-resistant Staphylococcus aureus, Klebsiella pneumonia and Pseudomonas aeruginosa with minimum inhibitory concentration ≤ 3.0 µg mL-1 as compared to the antibiotic agents' chloramphenicol and ampicillin, which were active at ≥ 6.25 mg mL-1. The extracts also exhibited anticancer activity in a dose-responsive pattern against HepG2 (with IC50, half maximal inhibitory concentration ~ 78-83 µg mL-1) and MCF7 (IC50 ~ 45-48 µg mL-1) on tetrazolium bromide screening assay with lesser cytotoxic effects on normal fibroblast (L929) cell lines (IC50 > 100 µg mL-1). The results revealed that seaweed-associated heterotrophic bacteria could occupy a predominant role for a paradigm shift towards the development of prospective anti-infective and anticancer agents.

    Item Type: Article
    Uncontrolled Keywords: Heterotrophic bacteria; Shewanella algae MTCC 12715; Bacillus amyloliquefaciens MTCC 12716; Anti-infective; Anticancer; Drug-resistant pathogens
    Subjects: Biochemistry > Bioprospecting
    Algae > Bacteria
    Biochemistry > Bioactive compounds
    Biochemistry
    Algae > Seaweed
    Divisions: CMFRI-Kochi > Marine Biotechnology
    Subject Area > CMFRI > CMFRI-Kochi > Marine Biotechnology
    CMFRI-Kochi > Marine Biotechnology
    Subject Area > CMFRI-Kochi > Marine Biotechnology
    Depositing User: Arun Surendran
    Date Deposited: 19 Mar 2021 06:11
    Last Modified: 19 Mar 2021 06:11
    URI: http://eprints.cmfri.org.in/id/eprint/15011

    Actions (login required)

    View Item View Item